Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
about
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyRandomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart DiseaseThe clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.Family practice patients' adherence to statin medications.Pneumococcal vaccination and risk of myocardial infarction.Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed populationUse of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention.Use of pharmacy records to measure treatment adherence: a critical review of the literature.A systematic review to assess adherence and persistence with statins.The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project.
P2860
Q33972105-4AD3C475-D8A8-4F73-B305-39890ACD3F8CQ34730092-3A74CE6F-D151-4E47-8AD3-F0995F58602EQ35843906-05DAA11A-36AC-45F3-833E-DF78B4C054EFQ36440488-5539CBA7-0AB1-4BC6-B673-598E1A4E55A5Q36909937-9732673B-50BE-4631-AB7B-B84E12DA5261Q37100610-5E5C9402-7CE2-431D-A920-CA867EFB66B7Q37224119-41EA67DE-436D-44BF-82EC-0FBD82321EEFQ37454427-4996E920-75AD-44ED-9D56-F9E8CA9A9909Q37897661-ED205E6D-4503-4B9E-87C3-8019394B5817Q38819475-E682A242-1319-4D83-AD23-A07FA59481ACQ39026831-D57E005D-CBCB-447A-B641-BED870036781Q42661766-BD906673-BC36-40D3-94A1-F5300B1AB622Q46225749-B0598962-7DED-4D2A-BF69-90992C713088
P2860
Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Persistence and adherence to c ...... urance Maladie du Québec data.
@ast
Persistence and adherence to c ...... urance Maladie du Québec data.
@en
type
label
Persistence and adherence to c ...... urance Maladie du Québec data.
@ast
Persistence and adherence to c ...... urance Maladie du Québec data.
@en
prefLabel
Persistence and adherence to c ...... urance Maladie du Québec data.
@ast
Persistence and adherence to c ...... urance Maladie du Québec data.
@en
P2093
P1476
Persistence and adherence to c ...... urance Maladie du Québec data.
@en
P2093
Elizabeth P Merikle
Jean Lachaine
Jean-Eric Tarride
Stephane Rinfret
P304
P356
10.1016/J.AHJ.2005.09.010
P407
P577
2006-07-01T00:00:00Z